US Stock MarketDetailed Quotes

BBIO BridgeBio Pharma

Watchlist

23.240
+0.200+0.87%

Close Nov 21 16:00 ET

23.300
+0.060+0.26%

Post 20:01 ET

4.39BMarket Cap-9603P/E (TTM)

BridgeBio Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-33.22%2.73M

32.11%2.17M

11,461.88%211.12M

-88.02%9.3M

-6.68%1.75M

1,110.36%4.09M

-97.77%1.64M

7.79%1.83M

11.38%77.65M

-85.49%1.87M

Operating revenue

-33.22%2.73M

32.11%2.17M

11,461.88%211.12M

-88.02%9.3M

-6.68%1.75M

1,110.36%4.09M

-97.77%1.64M

7.79%1.83M

11.38%77.65M

-85.49%1.87M

Cost of revenue

0.00%598K

-0.17%598K

-8.14%598K

-28.77%2.45M

-7.57%598K

-19.08%598K

-14.43%599K

-51.71%651K

10.28%3.43M

-58.28%647K

Gross profit

-38.91%2.13M

50.67%1.57M

17,816.77%210.52M

-90.76%6.86M

-6.21%1.15M

971.07%3.49M

-98.57%1.04M

239.60%1.18M

11.43%74.21M

-89.21%1.22M

Operating expense

17.62%189.26M

21.31%174.22M

66.80%206.78M

11.73%606.3M

44.84%177.81M

30.08%160.91M

-0.84%143.61M

-18.10%123.97M

-15.64%542.65M

-30.62%122.76M

Selling and administrative expenses

92.36%68.82M

64.78%59.52M

111.54%65.81M

5.17%150.59M

49.34%47.58M

14.71%35.78M

-0.83%36.12M

-28.84%31.11M

-25.50%143.19M

-41.80%31.86M

Research and development costs

-3.75%120.44M

6.70%114.7M

51.81%140.97M

14.08%455.71M

43.26%130.23M

35.27%125.14M

-0.84%107.49M

-13.74%92.86M

-11.43%399.46M

-25.61%90.9M

Operating profit

-18.87%-187.13M

-21.10%-172.65M

103.05%3.74M

-27.97%-599.44M

-45.35%-176.66M

-26.85%-157.42M

-98.62%-142.57M

18.69%-122.79M

18.76%-468.44M

26.61%-121.54M

Net non-operating interest income expense

-19.69%-19.77M

-10.34%-17.74M

-21.47%-19.4M

13.23%-63.25M

7.60%-14.69M

5.14%-16.51M

17.59%-16.08M

20.47%-15.97M

-59.70%-72.9M

-6.33%-15.9M

Non-operating interest income

-13.10%3.3M

15.09%5.2M

-1.88%4.08M

139.17%18.04M

36.31%5.58M

56.93%3.79M

489.30%4.51M

1,455.43%4.15M

565.67%7.54M

2,148.35%4.09M

Non-operating interest expense

13.57%23.06M

11.38%22.94M

16.65%23.47M

1.06%81.29M

1.39%20.27M

2.43%20.31M

1.55%20.59M

-1.10%20.12M

71.96%80.44M

32.09%19.99M

Other net income (expense)

867.60%42.64M

5,688.61%114.85M

-416.55%-20.51M

-83.34%9.44M

771.48%21.02M

-522.43%-5.56M

-102.32%-2.06M

86.87%-3.97M

58.23%56.68M

-111.07%-3.13M

Gain on sale of security

----

323.17%18.3M

----

113.51%1.4M

----

---8.2M

----

Earnings from equity interest

---6.56M

---7.93M

----

--0

----

Special income (charges)

985.74%49.2M

3,563.69%122.3M

-790.18%-29.99M

81.77%-9.13M

227.08%2.45M

-522.43%-5.56M

57.94%-3.53M

88.86%-3.37M

-239.76%-50.07M

-106.83%-1.93M

-Less：Restructuring and merger&acquisition

1,598.90%4.62M

-18.13%2.89M

-7.12%3.13M

-74.47%7.93M

-90.20%754K

-94.50%272K

-57.94%3.53M

-66.34%3.37M

--31.05M

--7.69M

-Less:Impairment of capital assets

--0

--271K

--0

--12.72M

--0

-Less:Other special charges

----

--26.59M

----

-Gain on sale of business

--52.03M

--125.19M

----

---1.2M

--0

----

-Gain on sale of property,plant,equipment

134.01%1.8M

----

-183.45%-5.28M

----

-117.59%-6.3M

-79.64%5.76M

Other non- operating income (expenses)

----

515.79%468K

1,677.87%9.48M

-99.77%270K

----

-99.93%76K

---601K

--114.95M

--7M

Income before tax

8.49%-164.25M

52.99%-75.54M

74.67%-36.16M

-34.79%-653.25M

-21.17%-170.33M

-28.03%-179.49M

-6,179.91%-160.7M

29.11%-142.73M

17.36%-484.65M

7.69%-140.57M

Income tax

Net income

8.49%-164.25M

52.99%-75.54M

74.67%-36.16M

-34.79%-653.25M

-21.17%-170.33M

-28.03%-179.49M

-6,179.91%-160.7M

29.11%-142.73M

17.36%-484.65M

7.69%-140.57M

Net income continuous Operations

8.49%-164.25M

52.99%-75.54M

74.67%-36.16M

-34.79%-653.25M

-21.17%-170.33M

-28.03%-179.49M

-6,179.91%-160.7M

29.11%-142.73M

17.36%-484.65M

7.69%-140.57M

Minority interest income

11.05%-2.21M

25.53%-2.09M

63.35%-944K

-189.68%-10.05M

26.82%-2.18M

12.79%-2.49M

-138.43%-2.8M

47.78%-2.58M

85.49%-3.47M

41.65%-2.98M

Net income attributable to the parent company

8.45%-162.04M

53.48%-73.46M

74.87%-35.22M

-33.67%-643.2M

-22.21%-168.15M

-28.88%-177M

-1,502.06%-157.9M

28.64%-140.16M

14.46%-481.18M

6.51%-137.59M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

8.45%-162.04M

53.48%-73.46M

74.87%-35.22M

-33.67%-643.2M

-22.21%-168.15M

-28.88%-177M

-1,502.06%-157.9M

28.64%-140.16M

14.46%-481.18M

6.51%-137.59M

Basic earnings per share

20.37%-0.86

60.20%-0.39

78.26%-0.2

-21.17%-3.95

-4.35%-0.96

-16.13%-1.08

-1,300.00%-0.98

31.85%-0.92

16.41%-3.26

8.91%-0.92

Diluted earnings per share

20.37%-0.86

60.20%-0.39

78.26%-0.2

-21.17%-3.95

-4.35%-0.96

-16.13%-1.08

-1,300.00%-0.98

31.85%-0.92

16.41%-3.26

8.91%-0.92

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	-33.22%2.73M	32.11%2.17M	11,461.88%211.12M	-88.02%9.3M	-6.68%1.75M	1,110.36%4.09M	-97.77%1.64M	7.79%1.83M	11.38%77.65M	-85.49%1.87M
Operating revenue	-33.22%2.73M	32.11%2.17M	11,461.88%211.12M	-88.02%9.3M	-6.68%1.75M	1,110.36%4.09M	-97.77%1.64M	7.79%1.83M	11.38%77.65M	-85.49%1.87M
Cost of revenue	0.00%598K	-0.17%598K	-8.14%598K	-28.77%2.45M	-7.57%598K	-19.08%598K	-14.43%599K	-51.71%651K	10.28%3.43M	-58.28%647K
Gross profit	-38.91%2.13M	50.67%1.57M	17,816.77%210.52M	-90.76%6.86M	-6.21%1.15M	971.07%3.49M	-98.57%1.04M	239.60%1.18M	11.43%74.21M	-89.21%1.22M
Operating expense	17.62%189.26M	21.31%174.22M	66.80%206.78M	11.73%606.3M	44.84%177.81M	30.08%160.91M	-0.84%143.61M	-18.10%123.97M	-15.64%542.65M	-30.62%122.76M
Selling and administrative expenses	92.36%68.82M	64.78%59.52M	111.54%65.81M	5.17%150.59M	49.34%47.58M	14.71%35.78M	-0.83%36.12M	-28.84%31.11M	-25.50%143.19M	-41.80%31.86M
Research and development costs	-3.75%120.44M	6.70%114.7M	51.81%140.97M	14.08%455.71M	43.26%130.23M	35.27%125.14M	-0.84%107.49M	-13.74%92.86M	-11.43%399.46M	-25.61%90.9M
Operating profit	-18.87%-187.13M	-21.10%-172.65M	103.05%3.74M	-27.97%-599.44M	-45.35%-176.66M	-26.85%-157.42M	-98.62%-142.57M	18.69%-122.79M	18.76%-468.44M	26.61%-121.54M
Net non-operating interest income expense	-19.69%-19.77M	-10.34%-17.74M	-21.47%-19.4M	13.23%-63.25M	7.60%-14.69M	5.14%-16.51M	17.59%-16.08M	20.47%-15.97M	-59.70%-72.9M	-6.33%-15.9M
Non-operating interest income	-13.10%3.3M	15.09%5.2M	-1.88%4.08M	139.17%18.04M	36.31%5.58M	56.93%3.79M	489.30%4.51M	1,455.43%4.15M	565.67%7.54M	2,148.35%4.09M
Non-operating interest expense	13.57%23.06M	11.38%22.94M	16.65%23.47M	1.06%81.29M	1.39%20.27M	2.43%20.31M	1.55%20.59M	-1.10%20.12M	71.96%80.44M	32.09%19.99M
Other net income (expense)	867.60%42.64M	5,688.61%114.85M	-416.55%-20.51M	-83.34%9.44M	771.48%21.02M	-522.43%-5.56M	-102.32%-2.06M	86.87%-3.97M	58.23%56.68M	-111.07%-3.13M
Gain on sale of security	----	----	----	323.17%18.3M	----	----	113.51%1.4M	----	---8.2M	----
Earnings from equity interest	---6.56M	---7.93M	----	----	----	--0	--0	----	----	----
Special income (charges)	985.74%49.2M	3,563.69%122.3M	-790.18%-29.99M	81.77%-9.13M	227.08%2.45M	-522.43%-5.56M	57.94%-3.53M	88.86%-3.37M	-239.76%-50.07M	-106.83%-1.93M
-Less：Restructuring and merger&acquisition	1,598.90%4.62M	-18.13%2.89M	-7.12%3.13M	-74.47%7.93M	-90.20%754K	-94.50%272K	-57.94%3.53M	-66.34%3.37M	--31.05M	--7.69M
-Less:Impairment of capital assets	--0	--0	--271K	--0	--0	--0	--0	--0	--12.72M	--0
-Less:Other special charges	----	----	--26.59M	----	----	----	----	----	----	----
-Gain on sale of business	--52.03M	--125.19M	----	---1.2M	---1.2M	--0	--0	----	----	----
-Gain on sale of property,plant,equipment	134.01%1.8M	----	----	----	----	-183.45%-5.28M	----	----	-117.59%-6.3M	-79.64%5.76M
Other non- operating income (expenses)	----	515.79%468K	1,677.87%9.48M	-99.77%270K	----	----	-99.93%76K	---601K	--114.95M	--7M
Income before tax	8.49%-164.25M	52.99%-75.54M	74.67%-36.16M	-34.79%-653.25M	-21.17%-170.33M	-28.03%-179.49M	-6,179.91%-160.7M	29.11%-142.73M	17.36%-484.65M	7.69%-140.57M
Income tax
Net income	8.49%-164.25M	52.99%-75.54M	74.67%-36.16M	-34.79%-653.25M	-21.17%-170.33M	-28.03%-179.49M	-6,179.91%-160.7M	29.11%-142.73M	17.36%-484.65M	7.69%-140.57M
Net income continuous Operations	8.49%-164.25M	52.99%-75.54M	74.67%-36.16M	-34.79%-653.25M	-21.17%-170.33M	-28.03%-179.49M	-6,179.91%-160.7M	29.11%-142.73M	17.36%-484.65M	7.69%-140.57M
Minority interest income	11.05%-2.21M	25.53%-2.09M	63.35%-944K	-189.68%-10.05M	26.82%-2.18M	12.79%-2.49M	-138.43%-2.8M	47.78%-2.58M	85.49%-3.47M	41.65%-2.98M
Net income attributable to the parent company	8.45%-162.04M	53.48%-73.46M	74.87%-35.22M	-33.67%-643.2M	-22.21%-168.15M	-28.88%-177M	-1,502.06%-157.9M	28.64%-140.16M	14.46%-481.18M	6.51%-137.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	8.45%-162.04M	53.48%-73.46M	74.87%-35.22M	-33.67%-643.2M	-22.21%-168.15M	-28.88%-177M	-1,502.06%-157.9M	28.64%-140.16M	14.46%-481.18M	6.51%-137.59M
Basic earnings per share	20.37%-0.86	60.20%-0.39	78.26%-0.2	-21.17%-3.95	-4.35%-0.96	-16.13%-1.08	-1,300.00%-0.98	31.85%-0.92	16.41%-3.26	8.91%-0.92
Diluted earnings per share	20.37%-0.86	60.20%-0.39	78.26%-0.2	-21.17%-3.95	-4.35%-0.96	-16.13%-1.08	-1,300.00%-0.98	31.85%-0.92	16.41%-3.26	8.91%-0.92
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data